These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 25636146)

  • 1. A virtual screen discovers novel, fragment-sized inhibitors of Mycobacterium tuberculosis InhA.
    Perryman AL; Yu W; Wang X; Ekins S; Forli S; Li SG; Freundlich JS; Tonge PJ; Olson AJ
    J Chem Inf Model; 2015 Mar; 55(3):645-59. PubMed ID: 25636146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance.
    Rawat R; Whitty A; Tonge PJ
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):13881-6. PubMed ID: 14623976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High affinity InhA inhibitors with activity against drug-resistant strains of Mycobacterium tuberculosis.
    Sullivan TJ; Truglio JJ; Boyne ME; Novichenok P; Zhang X; Stratton CF; Li HJ; Kaur T; Amin A; Johnson F; Slayden RA; Kisker C; Tonge PJ
    ACS Chem Biol; 2006 Feb; 1(1):43-53. PubMed ID: 17163639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan.
    Tseng ST; Tai CH; Li CR; Lin CF; Shi ZY
    J Microbiol Immunol Infect; 2015 Jun; 48(3):249-55. PubMed ID: 24184004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducing vulnerability to InhA inhibition restores isoniazid susceptibility in drug-resistant
    Harrison GA; Wang ER; Cho K; Mreyoud Y; Sarkar S; Almqvist F; Patti GJ; Stallings CL
    mBio; 2024 Mar; 15(3):e0296823. PubMed ID: 38294237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of modern InhA inhibitors to combat drug resistant strains of Mycobacterium tuberculosis.
    Tonge PJ; Kisker C; Slayden RA
    Curr Top Med Chem; 2007; 7(5):489-98. PubMed ID: 17346194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow-onset inhibition of 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis by an inorganic complex.
    Oliveira JS; de Sousa EH; de Souza ON; Moreira IS; Santos DS; Basso LA
    Curr Pharm Des; 2006; 12(19):2409-24. PubMed ID: 16842188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing mechanisms of resistance to the tuberculosis drug isoniazid: Conformational changes caused by inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis.
    Kruh NA; Rawat R; Ruzsicska BP; Tonge PJ
    Protein Sci; 2007 Aug; 16(8):1617-27. PubMed ID: 17600151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates from Xi'an, China.
    Zhou A; Nawaz M; Duan Y; Moore JE; Millar BC; Xu J; Yao Y
    Microb Drug Resist; 2011 Jun; 17(2):275-81. PubMed ID: 21388297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
    Oliveira JS; Pereira JH; Canduri F; Rodrigues NC; de Souza ON; de Azevedo WF; Basso LA; Santos DS
    J Mol Biol; 2006 Jun; 359(3):646-66. PubMed ID: 16647717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in the identification and development of InhA direct inhibitors of Mycobacterium tuberculosis.
    Lu XY; You QD; Chen YD
    Mini Rev Med Chem; 2010 Mar; 10(3):181-92. PubMed ID: 20408801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates.
    Morlock GP; Metchock B; Sikes D; Crawford JT; Cooksey RC
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3799-805. PubMed ID: 14638486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design of a novel class of potent inhibitors of InhA, the enoyl acyl carrier protein reductase from Mycobacterium tuberculosis: a computer modelling approach.
    Subba Rao G; Vijayakrishnan R; Kumar M
    Chem Biol Drug Des; 2008 Nov; 72(5):444-9. PubMed ID: 19012578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological evaluation of potent triclosan-derived inhibitors of the enoyl-acyl carrier protein reductase InhA in drug-sensitive and drug-resistant strains of Mycobacterium tuberculosis.
    Stec J; Vilchèze C; Lun S; Perryman AL; Wang X; Freundlich JS; Bishai W; Jacobs WR; Kozikowski AP
    ChemMedChem; 2014 Nov; 9(11):2528-37. PubMed ID: 25165007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel inhibitors of InhA efficiently kill Mycobacterium tuberculosis under aerobic and anaerobic conditions.
    Vilchèze C; Baughn AD; Tufariello J; Leung LW; Kuo M; Basler CF; Alland D; Sacchettini JC; Freundlich JS; Jacobs WR
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3889-98. PubMed ID: 21628538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia.
    Lavender C; Globan M; Sievers A; Billman-Jacobe H; Fyfe J
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4068-74. PubMed ID: 16189082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa.
    Kiepiela P; Bishop KS; Smith AN; Roux L; York DF
    Tuber Lung Dis; 2000; 80(1):47-56. PubMed ID: 10897383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A silent mutation in mabA confers isoniazid resistance on Mycobacterium tuberculosis.
    Ando H; Miyoshi-Akiyama T; Watanabe S; Kirikae T
    Mol Microbiol; 2014 Feb; 91(3):538-47. PubMed ID: 24354762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of isoniazid-NAD truncated adducts embedding a lipophilic fragment as potential bi-substrate InhA inhibitors and antimycobacterial agents.
    Delaine T; Bernardes-Génisson V; Quémard A; Constant P; Meunier B; Bernadou J
    Eur J Med Chem; 2010 Oct; 45(10):4554-61. PubMed ID: 20696503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis.
    Schaaf HS; Victor TC; Venter A; Brittle W; Jordaan AM; Hesseling AC; Marais BJ; van Helden PD; Donald PR
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1355-9. PubMed ID: 19861006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.